Collapsible Heart Valve with Polymer Leaflets

• US 20090112309A1
• Filed: 07/21/2006
• Published: 04/30/2009
• Est. Priority Date: 07/21/2005
• Status: Abandoned Application

• Current Assignee: The Florida International University Board of Trustees (State University System of Florida)
• Original Assignee: The Florida International University Board of Trustees (State University System of Florida)
• Inventors: Schoephoerster, Richard T., Jaramillo, Fernando
• Application Number:
  US11/993,948
• Publication Number:
  US 20090112309A1
• Time in Patent Office: Days
• US Class Current: 623/1.260
• CPC Class Codes: A61F 2/2412 with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/2415 Manufacturing methods
• CPC Class Codes: A61F 2/2418 Scaffolds therefor, e.g. support stents
• CPC Class Codes: A61F 2220/0008 Fixation appliances for connecting prostheses to the body
• CPC Class Codes: A61F 2230/0013 Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped

Abstract

A Catheter Based Heart Valve (CBHV) is described herein which replaces a non functional, natural heart valve. The CBHV significantly reduces the invasiveness of the implantation procedure by being inserted with a catheter as opposed to open heart surgery. Additionally, the CBHV is coated with a biocompatible material to reduce the thrombogenic effects and to increase durability of the CBHV. The CBHV includes a stent and two or more polymer leaflets sewn to the stent. The stent is a wire assembly coated with Polystyrene-Polyisobutylene-Polystyrene (SIBS). The leaflets are made from a polyester weave as a core material and are coated with SIBS before being sewn to the stent. Other biocompatible materials may be used, such as stainless steel, Titanium, Nickel-Titanium alloys, etc.

Claims

1. A human heart valve replacement comprising:

a collapsible stent formed from at least one length of wire, the wire having a series of turns forming a spring-like stent wall; and

at least one leaflet attached to the stent;

wherein the stent wall is collapsible in a radial direction such that a contracted diameter of the heart valve is smaller than an expanded diameter of the heart valve,

wherein the stent wall is spring biased to the expanded diameter, and

wherein the heart valve is sufficiently collapsible to be disposed within a catheter for insertion into a human heart.

2. The human heart valve replacement of claim 1, including three leaflets attached to the stent.

3. The human heart valve replacement of claim 2, wherein the leaflets are arranged in a double coaptation configuration.

4. The human heart valve replacement of claim 2, wherein the leaflets are arranged in a central coaptation configuration.

5. The human heart valve replacement of claim 1, wherein the at least one leaflet comprises a fabric selected from the group consisting of DACRON®

, Polyester and Polypropylene.

6. The human heart valve replacement of claim 1, wherein the at least one leaflet is less than approximately 280 microns thick.

7. The human heart valve replacement of claim 1, wherein the at least one leaflet comprises a material having a square thread pattern.

8. The human heart valve replacement of claim 7, wherein the material is arranged such that the leaflet has a higher elasticity along lines of coaptation and lower elasticity along a blood flow direction.

9. The human heart valve replacement of claim 1, further including a forward migration retainer extending from the stent wall.

10. The human heart valve replacement of claim 9, wherein the forward migration retainer comprises a hook.

11. The human heart valve replacement of claim 1, further including a backflow migration retainer extending from the stent wall.

12. The human heart valve replacement of claim 11, wherein the forward migration retainer comprises a hook.

13. The human heart valve replacement of claim 12, further including a forward migration retainer that comprises a hook.

14. The human heart valve replacement of claim 11, wherein the backflow migration retainer is adapted to engage a natural leaflet in a heart such that the natural leaflet is disposed between the stent wall and the backflow migration retainer and the backflow migration retainer is disposed between the natural leaflet and a vessel wall.

15. The human heart valve replacement of claim 1, wherein the wire is a nitinol wire.

16. The human heart valve replacement of claim 1, wherein the ratio between the expanded diameter and the contracted diameter is approximately 3:

1.

17. The human heart valve replacement of claim 1, wherein the stent wall is cylindrical in shape.

18. The human heart valve replacement of claim 1, wherein ends of the wire are joined with a hypodermic sleeve.

19. The human heart valve replacement of claim 1, wherein the expanded diameter is in the range of approximately 18 mm to approximately 27 mm.

20. The human heart valve replacement of claim 1, wherein the contracted diameter is in the range of approximately 6 mm to approximately 9 mm.

21. The human heart valve replacement of claim 1, wherein a length of the stent is in the range of approximately 12 mm to approximately 24 mm.

22. The human heart valve replacement of claim 1, wherein the stent and the at least one leaflet are coated with a biocompatible material.

23. The human heart valve replacement of claim 22, wherein the biocompatible material is SIBS.

24. The human heart valve replacement of claim 23, wherein the at least one leaflet is coated with a 20 ml solution of SIBS for 12 hours and dried at 80 degrees C.

25. A human heart valve replacement comprising:

a collapsible stent formed from at least one length of nitinol wire, the nitinol wire having a series of turns forming a spring-like stent wall;

a forward migration retainer extending from one end of the stent wall, the forward migration retainer being formed from a loop of the nitinol wire and adapted to engage a vessel wall to prevent migration of the replacement human heart valve in a blood flow direction;

a backflow migration retainer extending from another end of the stent wall, the backflow migration retainer being formed from a loop of the nitinol wire and adapted to engage a natural leaflet to prevent migration of the replacement human heart valve in a direction opposite to blood flow;

three leaflets having a thickness of less than 280 microns attached to the stent, the three leaflets forming a central coaptation arrangement;

wherein the stent wall is collapsible in a radial direction such that a contracted diameter of the replacement human heart valve is smaller than an expanded diameter of the replacement human heart valve,

wherein the stent wall is spring biased to the expanded diameter,

wherein the replacement human heart valve is sufficiently collapsible to be disposed within a catheter for insertion into a human heart, and

wherein the heart valve is coated with a boicompatable material.

26. A method of forming a stent for a replacement human heart valve, the method comprising:

attaching an end of a wire to a stent plate and attaching the other end of the wire to a tensor;

stretching the wire along a path determined by a plurality of pins on the stent plate;

thermally treating the stretched wire;

attaching the wire to a second plate;

bending portions of the wire to form a forward migration retainer and a backflow migration retainer;

thermally treating the stretched wire;

bending the stent into a substantially cylindrical shape; and

fixing the ends of the wire together within a hypodermic tube.

27. A method of forming a leaflet for a replacement human heart valve, the method comprising;

providing a sheet of material having a thickness of less than 280 microns;

soaking the sheet of material in a 20 ml solution of SIBS;

drying the sheet of material for approximately 12 hours at approximately 80 degrees C.; and

folding the sheet of material into one of a double coaptation arrangement and a central coaptation arrangement.

28. A method of inserting a human heart valve replacement into a human heart, the method comprising:

providing a replacement human heart valve comprising;

a collapsible stent formed from a length of wire, the wire having a series of turns forming a spring-like stent wall; and

a leaflet attached to the stent;

wherein the stent wall is collapsible in a radial direction such that a contracted diameter of the replacement human heart valve is smaller than an expanded diameter of the replacement human heart valve, the stent wall is spring biased to the expanded diameter, and the replacement human heart valve is sufficiently collapsible to be disposed within a catheter for insertion into a human heart;

compressing the stent to a diameter less than that of a catheter;

inserting the replacement human heart valve into the catheter;

inserting the catheter into the human heart; and

expanding the replacement human heart valve into an operational position in the human heart.

29. A leaflet for an artificial human heart valve comprising:

a sheet of woven fabric material;

wherein the sheet of woven material is both peripherally and centrally coaptable.

30. The leaflet of claim 29 wherein the woven fabric material is selected from the group consisting of DACRON®

, Polyester and Polypropylene.

31. The leaflet of claim 29 wherein the sheet of woven fabric material has two plies that form a double coaptation configuration.

32. The leaflet of claim 29, wherein a first ply coapts peripherally and a second ply coapts centrally.

33. The leaflet of claim 29, wherein the woven fabric material is folded and the free ends of the woven fabric material are downstream of the folded end of the woven fabric material in a direction of blood flow.

34. The leaflet of claim 29, wherein the sheet of woven material has a single centrally coapatable ply.

35. The leaflet of claim 34, wherein the ply coapts both centrally and peripherally.

36. The leaflet of claim 35, wherein the ply coapts centrally at one end and peripherally at another end.

37. The leaflet of claim 29, wherein the woven fabric material has a square weave pattern.

38. The leaflet of claim 29, wherein the woven fabric material is coated with a biocompatible material.

39. The leaflet of claim 38, wherein the biocompatible material is SIBS.

40. The leaflet of claim 29, wherein the woven fabric material is less than approximately 280 microns thick.

41. The leaflet of claim 29, wherein the woven fabric material has a higher elasticity along lines of coaptation and a lower elasticity along a flow direction.

42. The leaflet of claim 29, wherein three like pieces of woven fabric material form a substantially cylindrical shape, yet the peripheral coaptation provides a flexible in the peripheral geometry.